New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
GlaxoSmithKline (GSK)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
10.6B
10.1B
10.5B
10.9B
9.83B
Cost of Revenue
2.51B
2.74B
2.91B
2.68B
2.15B
Gross Profit
8.10B
7.39B
7.63B
8.18B
7.68B
Research & Development
1.55B
1.45B
1.51B
1.82B
1.37B
SG&A
3.40B
3.43B
3.59B
3.51B
3.16B
Amortization & Deprec
383M
380M
455M
528M
849M
Other Expenses
-104M
-10.1M
-27.4M
21.6M
15.2M
Total Operating Expenses
5.23B
5.25B
5.53B
5.88B
5.40B
Operating Income
2.87B
2.14B
2.11B
2.29B
2.28B
Other Income
509M
589M
649M
797M
172M
EBIT
3.38B
2.73B
2.76B
3.09B
2.45B
Minority Interest
104M
102M
119M
-41.8M
103M
Interest Expense
374M
300M
318M
296M
308M
Income Before Taxes
2.90B
2.33B
2.32B
2.84B
2.04B
Income Taxes
781M
365M
507M
1.47B
580M
Net Income from Continuing Ops
2.12B
1.97B
1.81B
1.37B
1.46B
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
2.12B
1.97B
1.81B
1.37B
1.46B
Preferred Dividends
0
0
0
0
0
Net Income to Common
2.12B
1.97B
1.81B
1.37B
1.46B
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour